Resmed Cdi revenue and financials
In the fiscal year ended June 2026, Resmed Cdi reported revenue of $5.65B (+9.85% year over year). Net income was $1.52B, a net margin of 26.9%.
Fiscal year ending in June. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +9.85%
- FY to Jun 2026 vs FY to Jun 2025
- Net income growth
- +8.75%
- FY to Jun 2026 vs FY to Jun 2025
- Net margin
- 26.9%
- FY to Jun 2025: 27.2%
How Resmed Cdi is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 12.1% a year on average over the last 5 years
Compound annual growth rate: from $3.2B in 2021 to $5.65B in 2026.
Revenue has grown for 9 fiscal years in a row
Each fiscal year compared with the one before, up to 2026.
Operating margin rose from 27.3% to 34.0%
Operating income over revenue, 2023 → 2026: 6.7 percentage points.
Profits turn into cash: free cash flow equal to 116% of net income
Totals for fiscal years 2024–2026: free cash flow $4.57B, net income $3.94B.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5,653 | 5,146 | 4,685 | 4,223 | 3,578 | 3,197 | 2,957 | 2,607 | 2,340 | 2,067 |
| Cost of revenue | 2,170 | 2,059 | 1,997 | 1,837 | 1,514 | 1,307 | 1,190 | 1,070 | 978 | 865 |
| Gross profit | 3,484 | 3,087 | 2,688 | 2,386 | 2,064 | 1,889 | 1,767 | 1,537 | 1,362 | 1,202 |
| Selling, general and administrative | 1,108 | 991 | 917 | 874 | 738 | 670 | 677 | 645 | 600 | 554 |
| Research and development | 378 | 331 | 308 | 288 | 254 | 225 | 202 | 181 | 155 | 144 |
| Operating income | 1,920 | 1,687 | 1,384 | 1,152 | 1,002 | 918 | 809 | 636 | 560 | 457 |
| EBIT | 1,920 | 1,687 | 1,384 | 1,152 | 1,002 | 918 | 809 | 636 | 560 | 457 |
| EBITDA | 2,096 | 1,860 | 1,534 | 1,292 | 1,126 | 1,029 | 923 | 753 | 660 | 569 |
| Interest expense | — | 0.6 | 49.7 | 51.1 | 22.3 | 23.6 | 39.4 | 36.2 | 28.4 | 28.2 |
| Pre-tax income | 1,919 | 1,678 | 1,265 | 1,102 | 960 | 884 | 733 | 519 | 521 | 419 |
| Income tax | 396 | 277 | 244 | 204 | 181 | 409 | 111 | 114 | 206 | 76.5 |
| Net income | 1,523 | 1,401 | 1,021 | 898 | 779 | 475 | 622 | 405 | 316 | 342 |
| Net income to common shareholders | 1,523 | 1,401 | 1,021 | 898 | 779 | 475 | 622 | 405 | 316 | 342 |
| Basic EPS | 10.47 | 9.55 | 6.94 | 6.12 | 5.34 | 3.27 | 4.31 | 2.83 | 2.21 | 2.42 |
| Diluted EPS | 10.43 | 9.51 | 6.92 | 6.09 | 5.30 | 3.24 | 4.27 | 2.80 | 2.19 | 2.40 |
| Average shares (basic) | 146 | 147 | 147 | 147 | 146 | 145 | 144 | 143 | 143 | 141 |
| Average shares (diluted) | 146 | 147 | 148 | 147 | 147 | 146 | 146 | 144 | 144 | 142 |
| Dividend per share | 2.40 | 2.12 | 1.92 | 1.76 | 1.68 | 1.59 | 1.56 | 1.50 | 1.42 | 1.34 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1,415 | 1,464 | 1,431 | 1,423 | 1,336 | 1,348 | 1,292 | 1,282 | 1,225 | 1,223 | 1,197 |
| Cost of revenue | 544 | 594 | 533 | 536 | 507 | 519 | 518 | 523 | 500 | 500 | 496 |
| Gross profit | 871 | 870 | 899 | 887 | 829 | 829 | 774 | 759 | 725 | 724 | 701 |
| Selling, general and administrative | 315 | 293 | 280 | 276 | 259 | 265 | 245 | 242 | 239 | 242 | 230 |
| Research and development | 103 | 106 | 94.3 | 91.0 | 87.3 | 86.4 | 83.9 | 81.4 | 79.5 | 80.9 | 77.1 |
| Operating income | 453 | 452 | 506 | 500 | 462 | 457 | 426 | 417 | 387 | 381 | 375 |
| EBIT | 544 | 452 | 506 | 500 | 462 | 457 | 426 | 417 | 387 | 381 | 375 |
| EBITDA | 596 | 490 | 558 | 544 | 504 | 514 | 464 | 457 | 426 | 418 | 411 |
| Interest expense | 4.8 | — | — | — | 7.1 | — | 2.1 | 3.7 | 4.4 | 2.2 | 13.4 |
| Pre-tax income | 539 | 474 | 502 | 496 | 447 | 458 | 418 | 418 | 383 | 358 | 375 |
| Income tax | 121 | 90.7 | 104 | 104 | 98.3 | 78.3 | 52.7 | 73.7 | 72.1 | 65.5 | 74.9 |
| Net income | 418 | 383 | 399 | 393 | 349 | 380 | 365 | 345 | 311 | 292 | 300 |
| Net income to common shareholders | 418 | 383 | 399 | 393 | 349 | 380 | 365 | 345 | 311 | 292 | 300 |
| Basic EPS | 0.29 | 2.65 | 2.74 | 2.69 | 2.38 | 2.59 | 2.49 | 2.35 | 2.12 | 1.99 | 2.04 |
| Diluted EPS | 0.29 | 2.64 | 2.74 | 2.68 | 2.37 | 2.58 | 2.48 | 2.34 | 2.11 | 1.98 | 2.04 |
| Average shares (basic) | 1,430 | 145 | 145 | 146 | 146 | 146 | 147 | 147 | 147 | 147 | 147 |
| Average shares (diluted) | 1,434 | 145 | 146 | 146 | 147 | 147 | 147 | 147 | 148 | 148 | 147 |
| Dividend per share | — | 0.60 | 0.60 | 0.60 | 0.60 | 0.53 | 0.53 | 0.53 | 0.53 | 0.48 | 0.48 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8,966 | 8,174 | 6,872 | 6,752 | 5,096 | 4,728 | 4,587 | 4,108 | 3,064 | 3,468 |
| Current assets | 4,325 | 3,506 | 2,358 | 2,368 | 1,931 | 1,575 | 1,523 | 1,145 | 1,066 | 1,644 |
| Cash and equivalents | 1,469 | 1,209 | 238 | 228 | 274 | 295 | 463 | 147 | 189 | 822 |
| Short-term investments | — | — | — | — | 9.2 | — | — | — | — | — |
| Receivables | 1,085 | 991 | 875 | 705 | 602 | 625 | 484 | 538 | 497 | 451 |
| Inventory | 973 | 976 | 994 | 1,141 | 851 | 464 | 417 | 350 | 269 | 268 |
| Net property, plant and equipment | 735 | 718 | 699 | 666 | 630 | 592 | 536 | 387 | 387 | 394 |
| Goodwill | 2,910 | 3,047 | 2,842 | 2,770 | 1,936 | 1,928 | 1,890 | 1,856 | 1,069 | 1,065 |
| Other intangible assets | 453 | 465 | 486 | 552 | 346 | 393 | 448 | 522 | 215 | 262 |
| Long-term investments | 157 | 140 | 139 | 134 | 49.2 | 40.2 | 44.1 | 52.1 | 41.2 | 38.3 |
| Current liabilities | 1,395 | 1,019 | 911 | 759 | 689 | 912 | 603 | 556 | 511 | 360 |
| Accounts payable | 309 | 278 | 238 | 151 | 159 | 138 | 136 | 116 | 92.7 | 92.8 |
| Long-term debt | 399 | 658 | 697 | 1,431 | 765 | 643 | 1,164 | 1,259 | 270 | 1,079 |
| Total debt | 826 | 852 | 874 | 1,580 | 918 | 794 | 1,299 | 1,271 | 281 | 1,079 |
| Total liabilities | 2,381 | 2,207 | 2,008 | 2,622 | 1,735 | 1,842 | 2,090 | 2,035 | 1,005 | 1,508 |
| Total equity (incl. minority) | 6,585 | 5,968 | 4,864 | 4,130 | 3,361 | 2,886 | 2,497 | 2,072 | 2,059 | 1,960 |
| Retained earnings | 7,255 | 6,081 | 4,992 | 4,253 | 3,614 | 3,080 | 2,833 | 2,436 | 2,432 | 2,316 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 8,212 | 8,966 | 8,784 | 8,503 | 8,308 | 8,174 | 7,567 | 7,141 | 7,222 | 6,872 | 6,815 |
| Current assets | 3,509 | 4,325 | 4,064 | 3,819 | 3,626 | 3,506 | 3,208 | 2,836 | 2,641 | 2,358 | 2,351 |
| Cash and equivalents | 1,011 | 1,469 | 1,661 | 1,417 | 1,384 | 1,209 | 933 | 522 | 426 | 238 | 238 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | 21.5 |
| Receivables | 1,024 | 1,085 | 1,046 | 1,047 | 958 | 991 | 991 | 960 | 811 | 875 | 817 |
| Inventory | 1,021 | 973 | 937 | 945 | 972 | 976 | 929 | 986 | 1,064 | 994 | 1,027 |
| Net property, plant and equipment | 798 | 735 | 729 | 730 | 726 | 718 | 688 | 671 | 717 | 699 | 687 |
| Goodwill | 2,908 | 2,910 | 3,043 | 3,044 | 3,044 | 3,047 | 2,849 | 2,805 | 2,886 | 2,842 | 2,836 |
| Other intangible assets | 443 | 453 | 425 | 430 | 447 | 465 | 430 | 438 | 479 | 486 | 501 |
| Long-term investments | — | 157 | 158 | 144 | 142 | 140 | 134 | 132 | 213 | 139 | 142 |
| Current liabilities | 1,324 | 1,395 | 1,351 | 1,248 | 1,256 | 1,019 | 941 | 852 | 904 | 911 | 773 |
| Accounts payable | 321 | 309 | 273 | 250 | 267 | 278 | 223 | 220 | 249 | 238 | 177 |
| Long-term debt | 250 | 399 | 404 | 404 | 409 | 658 | 663 | 663 | 668 | 697 | 997 |
| Total debt | 611 | 826 | 843 | 848 | 846 | 852 | 840 | 840 | 850 | 874 | 1,167 |
| Total liabilities | 2,264 | 2,381 | 2,292 | 2,182 | 2,187 | 2,207 | 2,021 | 1,888 | 2,027 | 2,008 | 2,185 |
| Total equity (incl. minority) | 5,948 | 6,585 | 6,492 | 6,321 | 6,121 | 5,968 | 5,546 | 5,253 | 5,195 | 4,864 | 4,630 |
| Retained earnings | 7,579 | 7,255 | 6,959 | 6,647 | 6,342 | 6,081 | 5,779 | 5,492 | 5,225 | 4,992 | 4,770 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jun 2026 | FY to Jun 2025 | FY to Jun 2024 | FY to Jun 2023 | FY to Jun 2022 | FY to Jun 2021 | FY to Jun 2020 | FY to Jun 2019 | FY to Jun 2018 | FY to Jun 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1,806 | 1,752 | 1,401 | 693 | 351 | 737 | 802 | 459 | 505 | 414 |
| Depreciation and amortization | 219 | 210 | 189 | 173 | 158 | 146 | 140 | 117 | 99.9 | 112 |
| Capital expenditure | -156 | -89.9 | -99.5 | -120 | -135 | -103 | -95.3 | -68.7 | -62.6 | -62.2 |
| Investing cash flow | -545 | -200 | -270 | -1,160 | -230 | -158 | -180 | -1,076 | -102 | -81.9 |
| Financing cash flow | -1,007 | -606 | -1,119 | 423 | -128 | -765 | -317 | 581 | -1,027 | -263 |
| Dividends paid | -350 | -311 | -282 | -258 | -245 | -227 | -225 | -212 | -199 | -186 |
| Share repurchases | -722 | -318 | -159 | -30.6 | -52.4 | -50.2 | -46.1 | -50.9 | -69.2 | -8.2 |
| Debt issued | 0.0 | 0.0 | 105 | 1,070 | 288 | 90.0 | 1,190 | 1,519 | 350 | 450 |
| Debt repaid | -10.0 | -40.0 | -835 | -405 | -166 | -612 | -1,284 | -712 | -1,146 | -545 |
| Effect of exchange rates | 6.2 | 25.8 | -1.7 | -2.1 | -14.4 | 18.5 | 10.9 | -5.6 | -9.7 | 21.2 |
| Net change in cash | 260 | 971 | 10.5 | -45.8 | -21.6 | -168 | 316 | -41.6 | -633 | 90.5 |
| Free cash flow | 1,629 | 1,651 | 1,286 | 559 | — | — | — | — | — | — |
| Levered free cash flow | 939 | 1,208 | 1,185 | 401 | 128 | 780 | 578 | 423 | 514 | 242 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 422 | 455 | 554 | 340 | 457 | 539 | 579 | 309 | 326 | 440 | 402 |
| Depreciation and amortization | 51.8 | 48.8 | 62.6 | 55.9 | 51.3 | 67.9 | 45.6 | 49.5 | 47.3 | 48.0 | 47.9 |
| Capital expenditure | -51.2 | -51.1 | -33.7 | -28.5 | -43.0 | -30.6 | -20.8 | -20.6 | -17.8 | -24.9 | -21.2 |
| Investing cash flow | 392 | -384 | -58.0 | -50.9 | -52.6 | -134 | -31.8 | -36.7 | 2.1 | -46.5 | -33.2 |
| Financing cash flow | -1,278 | -263 | -255 | -258 | -230 | -164 | -144 | -148 | -151 | -393 | -336 |
| Dividends paid | -95.0 | -87.1 | -87.2 | -87.6 | -87.8 | -77.6 | -77.7 | -77.7 | -77.9 | -70.6 | -70.5 |
| Share repurchases | -936 | -200 | -175 | -195 | -151 | -101 | -75.4 | -91.7 | -50.4 | -50.4 | -50.3 |
| Debt issued | — | — | — | — | — | 0.0 | 0.0 | — | — | 0.0 | 0.0 |
| Debt repaid | -250 | -5.0 | 0.0 | -5.0 | 0.0 | -5.0 | 0.0 | -5.0 | -30.0 | -300 | -220 |
| Effect of exchange rates | 5.0 | 0.9 | 2.6 | 2.8 | -0.1 | 35.6 | 8.0 | -28.8 | 11.1 | 0.1 | -5.3 |
| Net change in cash | -464 | -191 | 243 | 33.2 | 174 | 277 | 411 | 95.6 | 188 | 0.5 | 27.7 |
| Free cash flow | 371 | 397 | 515 | 305 | 412 | — | — | — | — | — | — |
| Levered free cash flow | — | -100 | 447 | 173 | 363 | 407 | 419 | 140 | 189 | 396 | 334 |
Financial statements of similar companies
Companies in the group: same industry, similar size
